No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
10 Health Care Stocks With Whale Alerts In Today's Session
Hims & Hers in Focus as Eli Lilly GLP-1 Sales Disappoint
Needham's Top Stocks for 2025: AX, CYBR, CART and More
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
Hims & Hers Health: Strong App Download Momentum and New Product Launches Drive Buy Recommendation
Watching Hims & Hers Health; Traders Circulate Popular Retail Trading Newsletter Saying Stock Is Poised For A Major Surge In 2025